ZURICH, May 19 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Thursday.
JULIUS BAER BAER.S
Swiss private bank Julius Baer said on Thursday its assets
under management rose 2 percent to 305 billion Swiss francs
($308.7 billion) in the first four months of the year.
urn:newsml:reuters.com:*:nFWN18F0S8
For more click on BAER.S
ROCHE ROG.S
Roche Holding won earlier-than-expected U.S. approval on
Wednesday for its bladder cancer drug Tecentriq, the company's
first entry in a new class of cancer drugs that work by
harnessing the body's own immune system. urn:newsml:reuters.com:*:nL3N18F4NX
The company said a phase III study of its drug Alecensa
(alectinib) showed the drug had reduced risk of disease
worsening or death by 66 percent compared to crizotinib in
Japanese people with advanced or recurrent, ALK-positive
non-small cell lung cancer. urn:newsml:reuters.com:*:nFWN18F0RU
The drugmaker also announced additional Swiss approval for
its cancer drug GAZYVARO (obinutuzumab) to treat patients with
previously treated follicular lymphoma. It was already approved
in 2014 to treat chronic lymphocytic leukaemia in combination
with chemotherapy in patients with other medical conditions.
For more click on ROG.S
COMPANY STATEMENTS CPR-CH
* Kuoni Reisen KUNN.S said EQT's public tender for the
Swiss travel group made on February 29 would be settled on
Thursday. KUNN.S
* gategroup GATE.S saw earnings before interest, tax,
depreciation and amortisation more than double year-on-year to
22 million Swiss francs in the first quarter, helping it reduce
its loss attributable to shareholders. GATE.S
* Orascom Development Holding ODHN.S saw revenues fall 18
percent in the first quarter as a strategic decision to reduce
land sales compounded with negative currency effects. ODHN.S
* Kudelski KUD.S said it had settled pending patent
litigation with Yahoo YHOO.O , with both parties agreeing to
dismiss pending lawsuits in exchange for a one-time up-front
license fee payment made to Kudelski by Yahoo. KUD.S
* Evolva EVE.S said Angela Tsetsis would join the
company's commercial team as Senior VP, Ingredient Solutions,
Health & Wellness. EVE.S
* Swiss Prime Site SPSN.S said first-quarter profit
decreased by 2.4 percent year on year to 48.8 million Swiss
francs and that it expects 2016 rental income and total
operating income above the previous year's level. SPSN.S
ECONOMY M-CH
(Reporting by Zurich newsroom)
((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit:
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German................ .SDE
All SMI constituent stocks............................ 0#.SSMI
News on major Swiss stock price moves.................. CH-HOT
FTSE Eurotop 300 index................................ .FTEU3
DJ STOXX index........................................ .STOXX
Top 10 STOXX sectors............................. .PGL.STOXXS
Top 10 EUROSTOXX sectors........................ .PGL.STOXXES
Top 10 Eurotop 300 sectors....................... .PGL.FTEU3S
Top 25 European pct gainers... .PG.PEUR , losers... .PL.PEUR
Swiss mid-cap index .SSMI SMI futures 0#SMI:
Swiss all-share index .SSHI Market statistics CH/STATS1
Swiss market digest .AD.S Sector overview CH/SECTOR1
All Swiss news CH Swiss research news CH-RCH
All equity news E
INTERNET ADDRESSES:
Swiss Exchange www.swx.ch/
Eurex www.eurexchange.com
STOXX Ltd www.stoxx.com
SPEED GUIDES: VX/EQUITY EQUITY EQUITY/NEWS1 EUR/EQUITY
SWITZERLAND REUTERS ))
Keywords: MARKETS SWISS STOCKS/